Señales en vivo de AVXL | Maximiza tus Ganancias con Getagraph.com

VENDER 122408 min ago

@ $5.61

Emitido: 13 feb 2024 @ 15:41

Retorno: -33.87%

Señal anterior: feb 13 - 09:30

Señal anterior: Comprar

Retorno: -3.28 %

Live Chart Being Loaded With Signals

Commentary (8 may 2024 @ 16:00):

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases...

Stats
Volumen de hoy	1.01M
Volumen promedio	1.27M
Capitalización de mercado	299.91M
EPS	$0 ( 2024-05-07 )
Próxima fecha de ganancias	( $-0.110 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.80
ATR14	$0.00600 (0.16%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-28	Missling Christopher U	Buy	73 380	Common Stock
2024-03-28	Missling Christopher U	Sell	73 380	Common Stock
2024-03-28	Missling Christopher U	Sell	73 380	Stock Option (Right to Buy)
2024-02-20	Donhauser Peter D.o.	Buy	50 000	Stock Option (Right to Buy)
2024-02-20	Thomas Steffen	Buy	50 000	Stock Option (Right to Buy)

INSIDER POWER
3.26
Last 100 transactions
Buy: 6 187 971 \| Sell: 2 192 392

Volumen Correlación

Largo: 0.03 (neutral)

Corto: 0.20 (neutral)

Signal:(55.898) Neutral

Anavex Life Sciences Corp Correlación

10 Correlaciones Más Positivas
GOODM	0.957
LGVN	0.918
CNEY	0.917
LMDX	0.916
RIDE	0.913
EBIX	0.912
MSEX	0.912
ASLE	0.905
VISL	0.903
BLCM	0.903

10 Correlaciones Más Negativas
ADAL	-0.929
BRIV	-0.921
XOG	-0.919
RNLC	-0.917
VMGA	-0.914
SPLK	-0.914
INBKZ	-0.909
SKYA	-0.908
JUGG	-0.907
TMKR	-0.907

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Anavex Life Sciences Corp Correlación - Moneda/Commodity

-0.15
( neutral )

0.00
( neutral )

-0.29
( neutral )

0.00
( neutral )

-0.10
( neutral )

Anavex Life Sciences Corp Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-0.600

FY	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-0.600

FY	2022
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-0.620

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.540

Financial Reports:

No articles found.

Anavex Life Sciences Corp

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the treatment of frontotemporal dementia and other dementia indications; and preclinical clinical trials for the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. Its preclinical drug candidates include ANAVEX 1-41, a sigma-1 receptor agonist for the treatment of depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.

Actualizaciones en tiempo real para Anavex Life Sciences Corp [AVXL]

Upcoming Earnings Alert